Estianeptine

N/A

Report date: 2023/09/06 14:02:29
NME

Base Information

Drug NameEstianeptine
Drug Alias Name(S)-Isomer of TianeptineTNX-4300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectantsPeroxisome proliferator-activated receptor delta agonistsPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor deltaPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDepressive Disorder, MajorBipolar DisorderAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTonix Pharmaceuticals Holding Corp
China Registration ClassN/A

Develop Information

Active CompaniesTonix Pharmaceuticals Holding Corp
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorBipolar DisorderAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A